<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363511">
  <stage>Registered</stage>
  <submitdate>17/01/2013</submitdate>
  <approvaldate>18/01/2013</approvaldate>
  <actrnumber>ACTRN12613000070730</actrnumber>
  <trial_identification>
    <studytitle>Vitamin D in critically ill patients with sepsis in Central Australia</studytitle>
    <scientifictitle>Measuring Vitamin D levels in patients admitted with sepsis and non sepsis in Central Australia to see if there is any difference in Vitamin D levels in these two groups</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hypovitaminosis D</healthcondition>
    <healthcondition>Sepsis</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Measuring Vitamin D level in patients admitted to Intensive care unit and High dependency unit.
Vitamin levels will be measured in blood samples taken on admission. It will be done once during patients admission.
Trial will commence from 1st March 2013 and continue till 31st December 2013</interventions>
    <comparator>All patients admitted to ICU/ HDU</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Incidence of hypovitaminosis D in critically ill patients.
Hypovitaminosis D is defined as Vitamin D levels in bloos samples less than 30ng/ml/
To see if there is any difference in vitamin D levels in septic and non-septic patients</outcome>
      <timepoint>baseline on admission to ICU/HDU</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>incidence of sepsis in patients admitted to ICU/HDU. This be assessed based on clinical assessment of patient along with blood results obtained from laboratory</outcome>
      <timepoint>with first 24 hrs of admission</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>all patients admitted to ICU/HDU and expected to stay for &gt; 48hrs
&gt; 18 yrs
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>patients expected to stay for &lt; 48 hrs</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/03/2013</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NT</recruitmentstate>
    <hospital>Alice Springs Hospital - Alice Springs</hospital>
    <postcode>0870 - Alice Springs</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>RAJENDRA GOUD</primarysponsorname>
    <primarysponsoraddress>PO Box:2234
Alice Springs Hospital
Alice Springs, NT-0870</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Indigenous Australians comprise a major proportion of the Central Australia population and there are a number of issues relating to those requiring critical care for sepsis, including higher rates of bacteraemia and poorer socio-economic status compared with non-indigenous populations in Australia. Despite high sunlight exposure in this region, it is thought that a combination of factors is likely to contribute to lower vitamin D levels among this population. The study will aim to establish baseline vitamin D levels in critically ill patients with sepsis in a Central Australian population. Our hypothesis is that there will be a significant degree of vitamin D deficiency in the critically ill, particularly among the septic cohort, and that it may be so prevalent as to justify routine supplementation in all critically ill patients without prior screening, further down the track</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central Australian Human Research Ethics Committee</ethicname>
      <ethicaddress>PO Box 4066
Alice Springs
NT 0871
</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>28/01/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Rajendra Goud</name>
      <address>PO Box:2234
Alice Springs Hospital
Alice Springs, NT-0870</address>
      <phone>+61889517696</phone>
      <fax />
      <email>Rajendra.Goud@nt.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Rajendra Goud</name>
      <address>PO Box:2234
Alice Springs Hospital
Alice Springs, NT-0870</address>
      <phone>+61889517696</phone>
      <fax />
      <email>Rajendra.Goud@nt.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Rajendra Goud</name>
      <address>Po Box: 2234
Alice Springs Hospital
Alice Springs, NT-0870</address>
      <phone>+61889517696</phone>
      <fax />
      <email>Rajendra.Goud@nt.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>